A disposable, passive microfluidic cartridge for point-of-care detection of antibodies in total capillary blood based on hemagglutination and machine-learning assisted interpretation

Point-of-care (PoC) detection of antibodies in blood enables rapid, on-site diagnosis. However, these devices often face challenges related to user variability due to the requirement of multiple manual operations. To address this issue, we designed and developed a disposable microfluidic device that requires minimal user input for rapid detection of SARS-CoV-2 antibodies (ABs) in total blood and antigens associated with blood types. Here, we present a passive pressure-driven pumping technique that rapidly mixes blood samples with reagents, delivering results within three minutes. The device requires 15 μL of capillary blood and can detect SARS-CoV-2 ABs across a concentration range of 0 to 60 μg mL<sup>-1</sup>. Additionally, we demonstrated the versatility of the microfluidic device by implementing blood typing functionality, highlighting its potential for broader serological testing applications. We also developed a support vector machine (SVM) algorithm as a proof-of-concept to demonstrate the potential application of machine learning (ML)-based analysis to complement visual interpretation of results. We evaluated the performance and predictive accuracy of the SVM model and compared it to human interpretations. The analysis showed that the SVM model achieved a statistically significant improvement in predicting varying degrees of agglutination when compared to human interpretation. This device addresses the need for a user-friendly, rapid COVID-19 AB testing solution and blood-typing assay and also provides a model for the future development of diagnostic devices that are integrated with ML models for improved diagnostic accuracy and accessibility in both clinical and non-clinical environments.

Authors

Institutions

Publication Details

Journal
RSC Advances
Published
2025-01-01
DOI
https://doi.org/10.1039/d5ra05719a
Primary Topic
Biosensors and Analytical Detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A disposable, passive microfluidic cartridge for point-of-care detection of antibodies in total capillary blood based on hemagglutination and machine-learning assisted interpretation

Mohammed A. Jawad, Afroza Tabassum Akhi, Vanessa Redecke, Ronald C. Wendling et al.
RSC Advances
Biosensors and Analytical Detection
article

A disposable, passive microfluidic cartridge for point-of-care detection of antibodies in total capillary blood based on hemagglutination and machine-learning assisted interpretation

Mohammed A. Jawad, Afroza Tabassum Akhi, Vanessa Redecke, Ronald C. Wendling, Bruce K. Gale, Hans Häcker
article en

Abstract

Point-of-care (PoC) detection of antibodies in blood enables rapid, on-site diagnosis. However, these devices often face challenges related to user variability due to the requirement of multiple manual operations. To address this issue, we designed and developed a disposable microfluidic device that requires minimal user input for rapid detection of SARS-CoV-2 antibodies (ABs) in total blood and antigens associated with blood types. Here, we present a passive pressure-driven pumping technique that rapidly mixes blood samples with reagents, delivering results within three minutes. The device requires 15 μL of capillary blood and can detect SARS-CoV-2 ABs across a concentration range of 0 to 60 μg mL<sup>-1</sup>. Additionally, we demonstrated the versatility of the microfluidic device by implementing blood typing functionality, highlighting its potential for broader serological testing applications. We also developed a support vector machine (SVM) algorithm as a proof-of-concept to demonstrate the potential application of machine learning (ML)-based analysis to complement visual interpretation of results. We evaluated the performance and predictive accuracy of the SVM model and compared it to human interpretations. The analysis showed that the SVM model achieved a statistically significant improvement in predicting varying degrees of agglutination when compared to human interpretation. This device addresses the need for a user-friendly, rapid COVID-19 AB testing solution and blood-typing assay and also provides a model for the future development of diagnostic devices that are integrated with ML models for improved diagnostic accuracy and accessibility in both clinical and non-clinical environments.

RSC AdvancesVol. 15(51)
University of Utah (US), Nanospectra Biosciences (United States) (US)
Openalex Percentile: Top 68%
Biosensors and Analytical Detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.